238 related articles for article (PubMed ID: 22056948)
21. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
22. Clinico-epidemiological study of endometrial hyperplasia--a risk factor for the development of endometrial carcinoma?
Cărăuleanu A; Lupaşcu IA; Cărăuleanu DM; Socolov R; Socolov D
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):154-61. PubMed ID: 25970959
[TBL] [Abstract][Full Text] [Related]
23. The value of additional pathology comments indicating suspicion of adenocarcinoma among women diagnosed preoperatively with complex atypical endometrial hyperplasia.
Suh-Burgmann E; Hung YY; Armstrong MA
Int J Gynecol Pathol; 2012 May; 31(3):222-6. PubMed ID: 22498938
[TBL] [Abstract][Full Text] [Related]
24. Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Am J Obstet Gynecol; 2010 Mar; 202(3):278.e1-6. PubMed ID: 20022581
[TBL] [Abstract][Full Text] [Related]
25. Endometrial hyperplasia and the risk of endometrial carcinoma.
Ho SP; Tan KT; Pang MW; Ho TH
Singapore Med J; 1997 Jan; 38(1):11-5. PubMed ID: 9269346
[TBL] [Abstract][Full Text] [Related]
26. Complex hyperplasia of the endometrium. Predictive value of curettage vs. hysterectomy specimens.
Lambert B; Muteganya D; Lepage Y; Boivin Y
J Reprod Med; 1994 Aug; 39(8):639-42. PubMed ID: 7996530
[TBL] [Abstract][Full Text] [Related]
27. The value of curettage in diagnosis of endometrial hyperplasia.
Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
[TBL] [Abstract][Full Text] [Related]
28. Intra-operative frozen section results reliably predict final pathology in endometrial cancer.
Stephan JM; Hansen J; Samuelson M; McDonald M; Chin Y; Bender D; Reyes HD; Button A; Goodheart MJ
Gynecol Oncol; 2014 Jun; 133(3):499-505. PubMed ID: 24699308
[TBL] [Abstract][Full Text] [Related]
29. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
30. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
31. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
32. Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review.
Pennant S; Manek S; Kehoe S
J Obstet Gynaecol; 2008 Aug; 28(6):632-3. PubMed ID: 19003662
[TBL] [Abstract][Full Text] [Related]
33. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
34. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study.
Kipp BR; Medeiros F; Campion MB; Distad TJ; Peterson LM; Keeney GL; Halling KC; Clayton AC
Cancer; 2008 Aug; 114(4):228-35. PubMed ID: 18548528
[TBL] [Abstract][Full Text] [Related]
35. The value of MRI in management of endometrial hyperplasia with atypia.
Natarajan P; Vinturache A; Hutson R; Nugent D; Broadhead T
World J Surg Oncol; 2020 Feb; 18(1):34. PubMed ID: 32041614
[TBL] [Abstract][Full Text] [Related]
36. Complex non atypical hyperplasia and the subsequent risk of carcinoma, atypia and hysterectomy during the following 9-14 years.
Iversen ML; Dueholm M
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():171-175. PubMed ID: 29413816
[TBL] [Abstract][Full Text] [Related]
37. Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage.
Suh-Burgmann E; Hung YY; Armstrong MA
Obstet Gynecol; 2009 Sep; 114(3):523-529. PubMed ID: 19701030
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia.
Shutter J; Wright TC
Int J Gynecol Pathol; 2005 Oct; 24(4):313-8. PubMed ID: 16175074
[TBL] [Abstract][Full Text] [Related]
39. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
